Beckman and R&D (research and development) Abs (Antibodies) form sepsis test deal
This article was originally published in Clinica
Executive Summary
Beckman Coulter has linked up with private firm Research and Diagnostic Antibodies (R&D Abs) in a deal for the development of tests for the early diagnosis and management of patients at risk for sepsis.